
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **HLA Genes (HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DRA, HLA-DQB1, HLA-DRB1, HLA-DMA):** These genes encode for major histocompatibility complex (MHC) class II molecules, which are crucial for antigen presentation to CD4+ T cells. Their presence suggests a role in immune response.<br>- **PTPRCAP, CD52, CD69, CD53:** These are involved in immune cell signaling and activation.<br>- **RAC2, CORO1A, LSP1:** These genes are involved in cytoskeletal organization and cell motility, which are important for immune cell function.<br>- **MEF2C:** A transcription factor involved in the regulation of immune cell differentiation and function.<br><br>### Step 2: List the Key Cell Type Markers<br>- **MS4A1 (CD20), CD19, CD79A, CD79B, BLK, BANK1:** These are classic markers for B cells. MS4A1 (CD20) and CD19 are surface proteins commonly used to identify B cells. CD79A and CD79B are components of the B cell receptor complex.<br>- **IGMH:** Immunoglobulin heavy chain mu, indicative of B cell lineage, particularly mature B cells or plasma cells.<br>- **POU2F2 (OCT2):** A transcription factor important for B cell development and function.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas, CellMarker, and literature on scRNA-seq datasets, the presence of MS4A1, CD19, CD79A, CD79B, and other B cell markers strongly suggests that these cells are of B cell lineage. The expression of HLA class II genes further supports this, as B cells are professional antigen-presenting cells.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of the markers, the most probable general cell type is **B cells**. The presence of both surface markers and functional genes related to B cell activity supports this conclusion.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Naive B Cells:** Characterized by the expression of CD19, CD20 (MS4A1), and other B cell receptor components without high levels of activation markers.<br>2. **Memory B Cells:** These cells would express similar markers but might show higher levels of activation markers like CD69.<br>3. **Plasma Cells:** While less likely due to the lack of high expression of plasma cell-specific markers like CD38, the presence of IGMH suggests some level of differentiation towards antibody production.<br><br>The most likely subtype, given the expression of MS4A1, CD19, and CD79A/B, is **Naive B Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The cluster of cells from the breast cancer tissue dataset is most likely composed of B cells, as indicated by the high expression of B cell-specific markers such as MS4A1 (CD20), CD19, CD79A, and CD79B. The presence of HLA class II genes supports their role in antigen presentation. Among B cells, the most probable subtype is naive B cells, given the expression profile and lack of strong activation or differentiation markers.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers such as MS4A1 (CD20), CD19, CD79A, CD79B, and others are classic markers for B cells, which are present in the marker list.<br>   - The presence of HLA class II genes (e.g., HLA-DRB5, HLA-DPA1, HLA-DPB1) supports the role of these cells in antigen presentation, consistent with B cells being professional antigen-presenting cells.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation does not suggest the presence of multiple distinct cell types strongly supported by several high-ranking markers. The markers predominantly indicate a B cell lineage.<br>   - The potential subtypes (naive B cells, memory B cells, plasma cells) are reasonable given the expression profile, and the annotation correctly identifies naive B cells as the most likely subtype based on the lack of strong activation or differentiation markers.<br><br>Overall, the annotation aligns well with the marker list and the expected cell type characteristics, leading to a valid conclusion of B cells, specifically naive B cells, as the most probable subtype.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">B cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Naive B Cells</li><li>Memory B Cells</li><li>Plasma Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its implications for identifying cell types within the dataset. The analysis correctly identifies the presence of B cell markers such as MS4A1 (CD20), CD19, CD79A, and CD79B, which are classic indicators of B cell lineage. The inclusion of HLA class II genes further supports the identification of these cells as B cells, given their role in antigen presentation.<br><br>The annotation process is thorough, as it considers both functional and cell type-specific markers, providing a balanced view of the data. The analysis does not overly focus on a single marker but instead integrates multiple markers to arrive at a comprehensive conclusion. This approach is evident in the identification of potential subtypes, such as naive B cells, memory B cells, and plasma cells, which are reasonable given the expression profile.<br><br>However, there are a few areas where the analysis could be improved. While the annotation correctly identifies naive B cells as the most likely subtype, it could have provided more detailed reasoning for why other subtypes, such as memory B cells or plasma cells, were less likely. Additionally, the analysis could have considered the rank of the markers more explicitly, as markers appearing earlier in the list may carry more weight in determining the cell type.<br><br>Overall, the annotation is scientifically accurate and provides a comprehensive view of the cell types present in the dataset. There are no obvious misclassifications or oversights, and the analysis captures the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    